<SEC-DOCUMENT>0001193125-24-248755.txt : 20241031
<SEC-HEADER>0001193125-24-248755.hdr.sgml : 20241031
<ACCEPTANCE-DATETIME>20241031164200
ACCESSION NUMBER:		0001193125-24-248755
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20241028
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241031
DATE AS OF CHANGE:		20241031

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Coya Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001835022
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41583
		FILM NUMBER:		241415809

	BUSINESS ADDRESS:	
		STREET 1:		12645 MEMORIAL DR., SUITE F1 #305
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77024
		BUSINESS PHONE:		650.739.3939

	MAIL ADDRESS:	
		STREET 1:		12645 MEMORIAL DR., SUITE F1 #305
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77024
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d840498d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:coya="http://www.coyatherapeutics.com/20241028" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-278">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-10-28_to_2024-10-28">0001835022</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="coya-20241028.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-10-28_to_2024-10-28"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001835022</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-10-28</xbrli:startDate> <xbrli:endDate>2024-10-28</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-289">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-10-28_to_2024-10-28" format="ixt:datemonthdayyearen" id="ixv-290">October&#160;28, 2024</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-291">Coya Therapeutics, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-10-28_to_2024-10-28" format="ixt-sec:stateprovnameen" id="ixv-292">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-293">001-41583</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-294">85-4017781</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(State or other jurisdiction<br/>of incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr></table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-295">5850 San Felipe St.</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-296">Suite 500</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-297">Houston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-10-28_to_2024-10-28" format="ixt-sec:stateprovnameen" id="ixv-298">Texas</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-299">77057</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-300">(800)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-301">587-8170</ix:nonNumeric></span></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report.)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-10-28_to_2024-10-28" format="ixt-sec:boolballotbox" id="ixv-302">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-10-28_to_2024-10-28" format="ixt-sec:boolballotbox" id="ixv-303">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-10-28_to_2024-10-28" format="ixt-sec:boolballotbox" id="ixv-304">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-10-28_to_2024-10-28" format="ixt-sec:boolballotbox" id="ixv-305">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-306">Common Stock, par value $0.0001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-307">COYA</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-10-28_to_2024-10-28" format="ixt-sec:exchnameen" id="ixv-308">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-10-28_to_2024-10-28" format="ixt-sec:boolballotbox" id="ixv-309">&#9746;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2024-10-28_to_2024-10-28" format="ixt-sec:boolballotbox" id="ixv-310">&#9744;</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;5.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On October&#160;28, 2024, the Compensation Committee of the Board of Directors (the &#8220;Board&#8221;) of Coya Therapeutics, Inc. (the &#8220;Company&#8221;) approved certain employment agreements with Dr.&#160;Howard Berman (the &#8220;Berman Employment Agreement&#8221;), the Company&#8217;s outgoing Chief Executive Officer, and Dr.&#160;Arun Swaminathan (the &#8220;Swaminathan Employment Agreement&#8221;), the Company&#8217;s incoming Chief Executive Officer and current Chief Business Officer. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed, effective October&#160;31, 2024, Dr.&#160;Berman resigned as the Company&#8217;s Chief Executive Officer and Dr.&#160;Swaminathan was appointed as the Company&#8217;s Chief Executive Officer, effective November&#160;1, 2024. After his resignation, Dr.&#160;Berman remains a member of the Board. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain biographical information about Dr.&#160;Swaminathan was previously disclosed in the Company&#8217;s current report on Form <span style="white-space:nowrap">8-K,</span> filed with the Securities and Exchange Commission on August 19, 2024, and is incorporated by reference herein. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Swaminathan Employment Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Swaminathan Employment Agreement provides for Dr.&#160;Swaminathan to serve as Chief Executive Officer and provides for an annual base salary of $525,000, subject to periodic review and adjustment in the sole discretion of the Board. In addition, Dr.&#160;Swaminathan is eligible to receive an annual bonus, which is targeted at up to 50% of his base salary but which may be adjusted by the Board based on achievement of goals and objectives established by the Company. Pursuant to the terms of the Swaminathan Employment Agreement, Dr.&#160;Swaminathan is eligible to receive, from time to time, equity awards under our existing equity incentive plan, or any other equity incentive plan the Company may adopt in the future, and the terms and conditions of such awards, if any, will be determined by the Board in its discretion. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Dr.&#160;Swaminathan is terminated for Cause (as defined in the Swaminathan Employment Agreement), all severance obligations under the Swaminathan Employment Agreement cease, except for payment of any Accrued Obligations (as defined in the Swaminathan Employment Agreement). If Dr.&#160;Swaminathan is terminated without Cause, he is due continued payment of his annual base salary for 12 months, and a pro rata portion of his annual bonus for the fiscal year in which the termination occurs, each contingent upon Dr.&#160;Swaminathan executing a severance and general release agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company or Dr.&#160;Swaminathan may terminate employment with the Company at any time, without any advance notice, for any reason or no reason at all. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Berman Employment Agreement </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Berman Employment Agreement provides for Dr.&#160;Berman to serve as Executive Chairman and provides for an annual base salary of $420,000. In addition, Dr.&#160;Berman is eligible to receive an annual bonus, which is targeted at up to 50% of his base salary but which may be adjusted by the Board based on achievement of goals and objectives established by the Company. Pursuant to the terms of the Berman Employment Agreement, Dr.&#160;Berman is eligible to receive, from time to time, equity awards under our existing equity incentive plan, or any other equity incentive plan the Company may adopt in the future, and the terms and conditions of such awards, if any, will be determined by the Board in its discretion. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Dr.&#160;Berman is terminated for Cause (as defined in the Berman Employment Agreement), the Company&#8217;s obligations under the agreement cease entirely, with the exception of any Accrued Obligations (as defined in the Berman Employment Agreement). If Dr.&#160;Berman is terminated without Cause, he is entitled to continued payment of his base salary for a period of 12 months, and a prorated annual bonus for the fiscal year in which termination occurs, each contingent upon Dr.&#160;Berman&#8217;s execution of a severance and general release agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company or Dr.&#160;Berman may terminate employment with the Company at any time, without any advance notice, for any reason or no reason at all. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;text-align:center">&#8195;No.&#8195;</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Description</td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d840498dex101.htm">Employment Agreement between Coya Therapeutics, Inc. and Dr.&#160;Arun Swaminathan, dated October&#160;30, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d840498dex102.htm">Employment Agreement between Coya Therapeutics, Inc. and Dr.&#160;Howard Berman, dated October&#160;30, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">COYA THERAPEUTICS, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: October&#160;31, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Howard Berman</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Howard Berman</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</p></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d840498dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMPLOYMENT AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Employment
Agreement (&#147;<B>Agreement</B>&#148;), effective as of November&nbsp;1, 2024 (&#147;<B>Effective Date</B>&#148;), is between Coya Therapeutics, Inc. (the &#147;<B>Company</B>&#148;) and Dr.&nbsp;Arun Swaminathan (&#147;<B>Executive</B>&#148;).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS, </B>the Company desires to employ Executive as its Chief Executive Officer, and Executive desires to accept such position. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the mutual covenants and promises contained in this Agreement, and other good and valuable consideration, the
receipt and sufficiency of which are acknowledged by the parties, the parties agree as follows. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Position, Responsibilities </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B> <B>Position</B>. Executive is employed by the Company to render services to the Company in the position of Chief Executive Officer.
In such role, Executive shall perform such duties and responsibilities as are normally related to such position in accordance with the standards of the industry and any additional duties now or hereafter assigned to Executive by the Board of
Directors (the &#147;<B>Board</B>&#148;) of the Company (the &#147;<B>Services</B>&#148;). Executive shall abide by the rules, regulations, and practices of the Company, as adopted or modified from time to time in the Company&#146;s sole discretion.
Executive will devote Executive&#146;s full efforts to the providing the Services under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> <B>Outside
Activities</B>. Notwithstanding the foregoing, Executive may (i)&nbsp;participate in such charitable, educational, religious, trade association, civic and similar types of organizations; (ii)&nbsp;serve on the board of directors (and board
committees) of <FONT STYLE="white-space:nowrap">non-profit</FONT> organizations and (iii)&nbsp;with the advance approval of the Board, engage in consulting arrangements, investment opportunities, employment positions and/or&nbsp;serve on boards of
directors (and board committees) (collectively, &#147;<B>Outside Activities</B>&#148;), provided that such Outside Activities do not, either individually or in the aggregate, conflict with or interfere with the business of the Company,
Executive&#146;s duties hereunder or create a potential business or fiduciary conflict. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>c.</B> <B>Other Activities</B>. Except upon
the prior written consent of the Board, Executive will not, during the term of this Agreement: (i)&nbsp;be employed elsewhere; (ii)&nbsp;engage, directly or indirectly, in any other business activity (whether or not pursued for pecuniary advantage)
that might interfere with Executive&#146;s duties and responsibilities hereunder or create a conflict of interest with the Company; or (iii)&nbsp;acquire any interest of any type in any other business which is in competition with the Company,
provided, however, that the foregoing shall not be deemed to prohibit the Executive from acquiring solely as an investment up to one percent (1%) of the outstanding equity interests of any publicly-held company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>d.</B> <B>No Conflict</B>. Executive represents and warrants that Executive&#146;s execution of this Agreement and performance of Services
under this Agreement will not violate any obligations Executive may have to any other employer, person or entity, including any obligations to keep in confidence proprietary information, knowledge, or data acquired by Executive in confidence or in
trust prior to becoming an employee of the Company. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Compensation and Benefits </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B> <B>Base Salary</B>. In consideration of the Services to be rendered under this Agreement, the Company shall pay Executive a gross
salary at the rate of $525,000 per year, less applicable withholdings, deductions and other taxes (&#147;<B>Base Salary</B>&#148;). The Base Salary shall be paid in accordance with the Company&#146;s normal payroll practices. Executive&#146;s Base
Salary will be reviewed from time to time in accordance with the established procedures of the Company for adjusting salaries for similarly situated senior executives of the Company and may be adjusted in the sole discretion of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> <B>Annual Bonus</B>. In further consideration of the Services to be rendered under this Agreement, Executive shall be eligible to
receive an annual discretionary bonus of up to fifty percent (50%) of Base Salary, less applicable withholdings (&#147;<B>Annual Bonus</B>&#148;). The amount of any Annual Bonus shall be at the sole discretion of the Board (or a committee thereof),
which shall make its determination based on the based on achievement of goals and objectives established by the Company. Any Annual Bonus earned by Executive will be paid within <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">two-and-one-half</FONT></FONT></FONT> months of the end of the year in which it was earned. Except as provided in Section&nbsp;4(b), Executive must remain employed with the Company through the end of the calendar year at
issue in order to be eligible to receive the Annual Bonus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>c.</B> <B>Employment Benefits Plans</B>. In further consideration of the
Services to be rendered under this Agreement, Executive will be entitled to participate in pension, profit sharing and other retirement plans, incentive compensation plans, group health, hospitalization and disability or other insurance plans, and
other employee welfare benefit plans generally made available to other similarly-situated employees of the Company, in accordance with the benefit plans established by the Company, and as may be amended from time to time in the Company&#146;s sole
discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>d.</B> <B>Vacation</B>. Executive shall be eligible to receive paid vacation consistent with the policies and procedures
adopted by the Company, if any, in its sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>e.</B> <B>Expenses</B>. The Company will pay or reimburse Executive for all
normal and reasonable travel and entertainment expenses incurred by Executive in connection with Executive&#146;s responsibilities to the Company upon submission of proper vouchers and documentation in accordance with the Company&#146;s expense
reimbursement policy. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">At-Will</FONT> Employment </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The employment of Executive shall be <FONT STYLE="white-space:nowrap">&#147;at-will&#148;</FONT> at all times. The Company or Executive may
terminate Executive&#146;s employment with the Company at any time, without any advance notice, for any reason or no reason at all, notwithstanding anything to the contrary contained in or arising from any statements, policies or practices of the
Company relating to the employment, discipline or termination of its employees. Following the termination of Executive&#146;s employment, the Company shall pay to Executive all compensation to which Executive is entitled up through the date of
termination and any employee benefits to which Executive is entitled (collectively, &#147;<B>Accrued Obligations</B>&#148;). Thereafter, all obligations of the Company under this Agreement shall cease other than those set forth in Section&nbsp;4.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Company Termination Obligations </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B> <B>Termination by Company for Cause</B>. Where the Company terminates Executive&#146;s employment for Cause, all obligations of the
Company under this Agreement shall cease, other than any Accrued Obligations. For purposes of this Agreement, &#147;<B>Cause</B>&#148; shall mean: (i)&nbsp;Executive engages in misconduct, including but not limited to misappropriation of trade
secrets, fraud, or embezzlement; (ii)&nbsp;Executive commits a crime involving dishonesty, breach of trust, or physical harm to any person; (iii)&nbsp;Executive breaches this Agreement; (iv)&nbsp;Executive refuses to implement or follow a lawful
policy or directive of the Company; (v)&nbsp;Executive engages in misfeasance or malfeasance demonstrated by Executive&#146;s failure to perform Executive&#146;s job duties diligently and/or professionally; or (vi)&nbsp;Executive violates a Company
policy or procedure which causes harm to the Company, including violation of the Company&#146;s policy concerning sexual harassment, discrimination or retaliation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> <B>Termination by Company without Cause</B>. Where the Company terminates Executive&#146;s employment without Cause, and
Executive&#146;s employment is not terminated due to death or Disability (as defined below), Executive will be eligible to receive, subject to applicable withholdings (i)&nbsp;continued payment of Base Salary for twelve (12)&nbsp;months following
the date that Executive&#146;s employment terminates according to the Company&#146;s normal payroll practices, and (ii)&nbsp;a pro rata portion of the Annual Bonus that would have been paid to Executive for the fiscal year in which Executive&#146;s
employment terminates which shall be payable when annual bonuses for such year are paid to other executives of the Company; provided that Executive&#146;s eligibility to receive the amounts in clauses (i)&nbsp;and (ii) of this Section&nbsp;4(b) is
conditioned on Executive having first signed a severance and general release agreement in the form provided by the Company and the release becoming irrevocable by its terms within fifty-five (55)&nbsp;calendar days following the date of
Executive&#146;s termination of employment (or, if applicable, the date of Executive&#146;s Separation from Service, as such term is defined in Section&nbsp;4(f)) and any payments that otherwise would have been paid to Executive during such period
shall be paid to Executive with the first installment paid to Executive following the end of such period. All other obligations of the Company under this Agreement shall cease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>c.</B> <B>Termination Due to Disability</B>. Executive&#146;s employment shall terminate automatically if Executive becomes Disabled.
Executive shall be deemed Disabled if Executive is unable for medical reasons to perform Executive&#146;s essential job duties for either ninety (90)&nbsp;consecutive calendar days or one hundred twenty (120)&nbsp;business days in a twelve
(12)&nbsp;month period and, within thirty (30)&nbsp;days after a notice of termination is given to Executive, Executive has not returned to work. If Executive&#146;s employment is terminated by the Company due to Executive&#146;s Disability, all
obligations of the Company under this Agreement shall cease, other than any Accrued Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>d.</B> <B>Termination Due to
Death</B>. Executive&#146;s employment shall terminate automatically upon Executive&#146;s death. If Executive&#146;s employment is terminated due to Executive&#146;s death, all obligations of the Company under this Agreement shall cease, other than
any Accrued Obligations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>e.</B> <B>Executive&#146;s Resignation</B>. Executive may resign Executive&#146;s
employment at any time, and thereafter, all obligations of the Company under this Agreement shall cease, other than any Accrued Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>f.</B> <B>Section 409A; Delayed Payments</B>. To the extent applicable, the provisions in this Section&nbsp;4 are intended to comply with
Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, and guidance promulgated thereunder (&#147;<B>409A</B>&#148;) and this Agreement shall be administered and construed in a manner consistent with this intent. In the event that any
compensation that becomes payable to Executive pursuant to this Section&nbsp;4 qualifies as a deferral of compensation within the meaning of and subject to 409A, then, notwithstanding anything to the contrary in this Agreement (i)&nbsp;such
compensation shall be paid to Executive only in the event of Executive&#146;s &#147;separation from service&#148; with the Company within the meaning of 409A (&#147;<B>Separation from Service</B>&#148;) and (ii)&nbsp;payment of that compensation
shall be delayed if Executive is a &#147;<B>specified employee,</B>&#148; as defined in 409A(a)(2)(B)(i), and such delayed payment is required by 409A. Such delay shall last six (6)&nbsp;months from the date of Executive&#146;s Separation from
Service. On the Company&#146;s first payroll date that occurs after the end of such <FONT STYLE="white-space:nowrap">six-month</FONT> period, the Company shall make a <FONT STYLE="white-space:nowrap">catch-up</FONT> payment to Executive equal to the
total amount of such payments that would have been made during the <FONT STYLE="white-space:nowrap">six-month</FONT> period but for this Section&nbsp;4(g). To the extent applicable, each and every payment to be made pursuant to Section&nbsp;4(b)
shall be treated as a separate payment and not as one of a series of payments treated as a single payment for purposes of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2)(iii).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>g.</B> <B>Retainment of Rights</B>. This Agreement is separate and independent from the other agreements governing Executive&#146;s equity
in the Company and its organizational documents and for the avoidance of doubt, any termination of Executive&#146;s employment shall have no effect on his rights therein. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Executive Termination Obligations </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B> <B>Return of Property</B>. Executive agrees that all property (including without limitation all equipment, tangible proprietary
information, documents, records, notes, contracts and computer-generated materials) furnished to or created or prepared by Executive incident to Executive&#146;s employment belongs to the Company and shall be promptly returned to the Company upon
termination of Executive&#146;s employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> <B>Resignation and Cooperation</B>. Upon termination of Executive&#146;s
employment, Executive shall be deemed to have resigned from all offices and directorships then held with the Company. Following any termination of employment, Executive shall cooperate with the Company in the winding up of pending work on behalf of
the Company and the orderly transfer of work to other employees. Executive shall also cooperate with the Company in the defense of any action brought by any third party against the Company that relates to Executive&#146;s employment by the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>c.</B> <B>Continuing Obligations</B>. Executive understands and agrees that Executive&#146;s obligations under Sections 6 and 7 herein
(including <U>Exhibits A</U> and <U>B</U>), and Section&nbsp;8 hereof shall survive the termination of Executive&#146;s employment for any reason and the termination of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Inventions and Proprietary Information </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Executive agrees to continue to be bound by the terms of the Proprietary Information and Inventions Agreement, which is attached as <U>Exhibit
A</U> (&#147;<B>Proprietary Information Agreement</B>&#148;). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Arbitration </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive agrees to continue to be bound by the terms of the Mutual Arbitration Agreement, which is attached as Exhibit B (&#147;<B>Mutual Arbitration
Agreement</B>&#148;). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>8.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B><FONT STYLE="white-space:nowrap">Non-Competition</FONT> </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive acknowledges and agrees with the Company that, during the course of Executive&#146;s employment with the Company, Executive has had and will continue
to have the opportunity to develop relationships with existing employees, customers, suppliers and other business contacts of the Company, which relationships constitute goodwill of the Company, and the Company would be irreparably damaged if
Executive were to take actions that would damage or misappropriate such goodwill. Accordingly, Executive agrees as follows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B>
<B><U>Noncompetition and Nonsolicitation</U></B>. In connection with Executive&#146;s employment, the Company agrees to provide Executive with access to confidential business and technical information of the Company and to provide Executive access
to its customers. To protect the legitimate business interests of the Company, including its trade secrets, confidential information, and goodwill, other than as excepted herein or with the written consent of the Board, Executive covenants and
agrees that, from the Effective Date and for the six (6)&nbsp;month period following the termination date of Executive&#146;s employment for any reason (the <B>&#147;Restricted Period&#148;</B>)<B>, </B>Executive will not, directly or indirectly,
either for himself or for any other Person: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) enter into, engage in, assist, give or lend funds to or otherwise finance, be employed by
or consult with, or have a financial or other interest in, a Competing Business in the United States, whether for or by himself or as an independent contractor, agent, stockholder, partner or joint venturer of or for any other Person (provided that
the foregoing shall not prohibit Executive from working for a Person that engages in a Competing Business as long as the business unit within which Executive is employed or otherwise performing services and Executive&#146;s actual services for such
Person are in no way engaged, directly or indirectly, in any Competing Business and provided further that nothing in this Section shall be construed to affect in any way Executive&#146;s confidentiality obligations as set forth in the Proprietary
Information Agreement. A &#147;<B>Competing Business</B>&#148; means any Person, that competes, whether or not for profit, with the business, products or services of the Company, including services and products that are under development by the
Company or which the Company has substantive plans to develop or engage in, including without limitation and Person engaged in therapeutic development of any <FONT STYLE="white-space:nowrap">Interleukin-2</FONT>
<FONT STYLE="white-space:nowrap">(IL-2)</FONT> containing drug, <FONT STYLE="white-space:nowrap">CTLA-4</FONT> Ig Fusion Protein <FONT STYLE="white-space:nowrap">(CTLA-4</FONT> Ig) containing drug, or combination thereof, or any Exosome Product. The
term &#147;<B>Person</B>&#148;, for purposes of this Agreement, shall mean any individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including a government or political subdivision or an
agency or instrumentality thereof. The foregoing shall not be deemed to prohibit the Executive from acquiring solely as an investment up to one percent (1%) of the outstanding equity interests of any publicly-held company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) do anything to divert or attempt to divert from the Company any business of any kind,
including, without limitation, solicit or interfere with any of the Company&#146;s clients or other business partners with whom the Executive performed direct, substantive services during his employment or as to whom the Executive had access to
confidential information where his use or disclosure of confidential information could disadvantage the Company; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) solicit,
induce, recruit, encourage or hire any person engaged or employed by the Company to terminate his or her employment or engagement with the Company.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> Executive acknowledges that the covenants provided for in this Section&nbsp;8 are reasonable and necessary to protect the legitimate
business interests of the Company, including its trade secrets, confidential information, and goodwill. Nevertheless, to the extent that the covenants provided for in this Section&nbsp;8&nbsp;may later be deemed by a court or arbitrator to impose a
greater restraint than is necessary to protect the goodwill or other business interests of the Company, such covenants shall be reformed, blue penciled or modified to the extent necessary to cause the limitations contained in the covenants as to
time, geographic area, and scope of activity to be restrained to impose a restraint that is not greater than necessary to protect the goodwill or other business interests of the Company and enforce the covenant as reformed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><U>c.</U></B> <B><U>Executive Acknowledgment</U></B>. Executive understands that the foregoing restrictions may limit his ability to earn a
livelihood in a business similar to the business of the Company, but he nevertheless believes that he has received and will receive sufficient consideration and other benefits as an employee of the Company and as otherwise provided hereunder or as
described in the recitals hereto to clearly justify such restrictions which, in any event (given his education, skills and ability), Executive does not believe such restrictions would prevent him from otherwise earning a living. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><U>d.</U></B> <B><U>Injunctive Relief</U></B>. Executive recognizes and agrees that a violation of any of the provisions contained in
Section&nbsp;8&nbsp;may cause irreparable damage to the Company, the exact amount of which may be impossible to ascertain, and that, for such reason, among others, the Company shall be entitled to seek an injunction without the necessity of posting
bond therefor in order to restrain any further violation of such provisions. Such right to seek an injunction shall be in addition to, and not in limitation of, any other rights and remedies the Company may have against Executive, including, but not
limited to, the recovery of damages. The terms and conditions of this Section&nbsp;8 shall survive termination of this Agreement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Amendments; Waivers; Remedies </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement may not be amended or waived except by a writing signed by Executive and by the Company&#146;s Board. Failure to exercise any right under this
Agreement shall not constitute a waiver of such right. Any waiver of any breach of this Agreement shall not operate as a waiver of any subsequent breaches. All rights or remedies specified for a party herein shall be cumulative and in addition to
all other rights and remedies of the party hereunder or under applicable law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>10.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Assignment; Binding Effect </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B> <B>Assignment</B>. The performance of Executive is personal hereunder, and Executive agrees that Executive shall have no right to
assign and shall not assign or purport to assign any rights or obligations under this Agreement. This Agreement may be assigned or transferred by the Company; and nothing in this Agreement shall prevent the consolidation, merger or sale of the
Company or a sale of any or all or substantially all of its assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> <B>Binding Effect</B>. Subject to the foregoing restriction
on assignment by Executive, this Agreement shall inure to the benefit of and be binding upon each of the parties; the affiliates, officers, directors, agents, successors and assigns of the Company; and the heirs, devisees, spouses, legal
representatives and successors of Executive. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>11.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Notices </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All notices or other communications required or permitted hereunder shall be made in writing and shall be deemed to have been duly given if delivered:
(a)&nbsp;by hand; (b)&nbsp;by a nationally recognized overnight courier service; or (c)&nbsp;by United States first class registered or certified mail, return receipt requested, to the principal address of the other party. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>12.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Severability </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any provision of this Agreement shall be held by a court or arbitrator to be invalid, unenforceable, or void, such provision shall be enforced to the
fullest extent permitted by law, and the remainder of this Agreement shall remain in full force and effect. In the event that the time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the
maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall reduce the time period or scope to the maximum time period or scope permitted by law. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Taxes </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All amounts paid under this Agreement shall be paid less all applicable state and federal tax withholdings and any other withholdings required by any
applicable jurisdiction. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Governing Law </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement shall be governed by and construed in accordance with the laws of the State of Texas. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Interpretation </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement shall be construed as a whole, according to its fair meaning, and not in favor of or against any party. Sections and section headings contained
in this Agreement are for reference purposes only, and shall not affect in any manner the meaning or interpretation of this Agreement. Whenever the context requires, references to the singular shall include the plural and the plural the singular.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Obligations Survive Termination of Employment </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive agrees that any and all of Executive&#146;s obligations under this Agreement, including but not limited to Exhibits A and B, shall survive the
termination of employment and the termination of this Agreement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Counterparts </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement may be executed in any number of counterparts, each of which shall be deemed an original of this Agreement, but all of which together shall
constitute one and the same instrument. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>18.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Authority </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each party represents and warrants that such party has the right, power and authority to enter into and execute this Agreement and to perform and discharge all
of the obligations hereunder; and that this Agreement constitutes the valid and legally binding agreement and obligation of such party and is enforceable in accordance with its terms. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>19.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Entire Agreement </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement is intended to be the final, complete, and exclusive statement of the terms of Executive&#146;s employment by the Company and replaces and
supersedes any prior agreements or understandings pertaining to the Executive&#146;s employment with the Company, including without limitation that certain Employment Agreement between Executive and the Company dated April 3, 2023. This Agreement
may not be contradicted by evidence of any prior or contemporaneous statements or agreements, except for agreements specifically referenced herein (including the Proprietary Information Agreement, and Mutual Arbitration Agreement). To the extent
that the practices, policies or procedures of the Company, now or in the future, apply to Executive and are inconsistent with the terms of this Agreement, the provisions of this Agreement shall control. Any subsequent change in Executive&#146;s
duties, position, or compensation will not affect the validity or scope of this Agreement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>20.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Executive Acknowledgement </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EXECUTIVE ACKNOWLEDGES EXECUTIVE HAS HAD THE OPPORTUNITY TO CONSULT LEGAL COUNSEL CONCERNING THIS AGREEMENT, THAT EXECUTIVE HAS READ AND UNDERSTANDS THE
AGREEMENT, THAT EXECUTIVE IS FULLY AWARE OF ITS LEGAL EFFECT, AND THAT EXECUTIVE HAS ENTERED INTO IT FREELY BASED ON EXECUTIVE&#146;S OWN JUDGMENT AND NOT ON ANY REPRESENTATIONS OR PROMISES OTHER THAN THOSE CONTAINED IN THIS AGREEMENT. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the parties have duly
executed this Agreement as of the date first written above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">COYA THERAPEUTICS, INC. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ David S. Snyder</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">/s/ Arun Swaminathan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: David S. Snyder</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Dr.&nbsp;Arun Swaminathan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its: CFO/COO</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: October&nbsp;30, 2024</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Dated: October&nbsp;30, 2024</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPRIETARY INFORMATION AGREEMENT </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MUTUAL ARBITRATION AGREEMENT </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>d840498dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMPLOYMENT AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Employment
Agreement (&#147;<B>Agreement</B>&#148;), dated November&nbsp;1, 2024 (&#147;<B>Effective Date</B>&#148;), is between Coya Therapeutics, Inc. (the &#147;<B>Company</B>&#148;) and Howard Berman (&#147;<B>Executive</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS, </B>Company and Executive are parties to that certain Executive Employment Agreement (the &#147;<B>Original Agreement</B>&#148;) dated
December&nbsp;15, 2020 pursuant to which Executive serves as Chief Executive Officer of the Company which Original Agreement was supplemented via addendum dated April&nbsp;1, 2022; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREA</B>S, Executive also serves as Chairman of the Board of Directors (the &#147;<B>Board</B>&#148;) of the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>WHEREAS, </B>the Company and the Executive have mutually agreed that Executive will no longer be Chief Executive Officer but will continue to be employed
by the Company in the capacity of Executive Chairman, and wish to terminate the Original Agreement and enter into this Agreement embodying the terms of such employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, in consideration of the mutual covenants and promises contained in this Agreement, and other good and valuable consideration, the
receipt and sufficiency of which are acknowledged by the parties, the parties agree as follows. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Position, Responsibilities, and Term </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B> <B>Position</B>. Executive is employed by the Company to render services to the Company in the position of Executive Chairman. In
such role, Executive shall perform such duties and responsibilities as are normally related to such position in accordance with the standards of the industry and any additional duties now or hereafter assigned to Executive by the Board (the
&#147;<B>Services</B>&#148;). Without limitation of the foregoing, Executive&#146;s Services shall include but not be limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mentoring and providing counseling to the Company&#146;s Chief Executive Officer (&#147;<B>CEO</B>&#148;).
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Working with the CEO to identify opportunities for value-enhancing strategic initiatives including
acquisitions, joint ventures, and strategically important relationships. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Facilitating the visible transfer of decision-making power to the CEO and ensuring all stakeholders are aligned
with the transition. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iv.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Attending meetings as needed with the Board, company leadership, business partners, vendors, employees and
others. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">v.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Assisting on intellectual property discussions related to the Company&#146;s portfolio. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive shall abide by the rules, regulations, and practices of the Company, as adopted or modified from time to time in the Company&#146;s sole discretion.
Executive will devote sufficient business time and attention as required to perform the Services under this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> Notwithstanding the foregoing, Executive may (i)&nbsp;participate in such
charitable, educational, religious, trade association, civic and similar types of organizations; (ii)&nbsp;serve on the board of directors (and board committees) of <FONT STYLE="white-space:nowrap">non-profit</FONT> organizations and
(iii)&nbsp;engage in consulting arrangements, investment opportunities, employment positions and/or&nbsp;serve on boards of directors (and board committees) (collectively, &#147;<B>Outside Activities</B>&#148;), provided that such Outside Activities
do not, either individually or in the aggregate, conflict with or interfere with the business of the Company, Executive&#146;s duties hereunder or create a potential business or fiduciary conflict. Without limitation of the foregoing, such Outside
Activities may not be provided to Persons (as defined below) that are engaged in therapeutic development of any <FONT STYLE="white-space:nowrap">Interleukin-2</FONT> <FONT STYLE="white-space:nowrap">(IL-2)</FONT> containing drug, <FONT
STYLE="white-space:nowrap">CTLA-4</FONT> Ig Fusion Protein <FONT STYLE="white-space:nowrap">(CTLA-4</FONT> Ig) containing drug, or combination thereof, as well as any Exosome Product (each, a &#147;<B>Competing Business</B>&#148;).
&#147;<B>Person</B>&#148;, for purposes of this Agreement, shall mean any individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including a government or political subdivision or an
agency or instrumentality thereof. If the Board or a committee thereof determines that any such Outside Activities are or can reasonably be expected to be in violation of the foregoing or the Proprietary Information Agreement referenced in
Section&nbsp;6 hereof, Executive shall promptly cease such Outside Activities upon written notice thereof by the Board or such committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>c.</B> <B>Other Activities</B>. Except upon the prior written consent of the Company, Executive will not, during the term of this
Agreement: (i)&nbsp;acquire any interest of any type in any Competing Business, provided, however, that the foregoing shall not be deemed to prohibit the Executive from acquiring solely as an investment up to one percent (1%) of the outstanding
equity interests of any publicly-held company. A &#147;<B>Competing Business</B>&#148; shall have the meaning set forth in Section&nbsp;1(b) hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>d.</B> <B>No Conflict</B>. Executive represents and warrants that Executive&#146;s execution of this Agreement and performance of Services
under this Agreement will not violate any obligations Executive may have to any other employer, person or entity, including any obligations to keep in confidence proprietary information, knowledge, or data acquired by Executive in confidence or in
trust prior to becoming an employee of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>e.</B> <B>Term of Employment</B>. The Term of Employment under this Agreement, and
the employment of Executive hereunder shall commence on the Effecive Date and shall continue until terminated in accordance with Section&nbsp;3 below (the <B>&#147;Term of Employment&#148;</B>). Where the Agreement is terminated upon notice, the
Company shall pay to Executive all compensation to which Executive is entitled up through the effective date of termination according to its normal payroll practices, and the Company shall not have any further obligations under this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Compensation and Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B>
<B>Base Salary</B>. In consideration of the Services to be rendered under this Agreement, the Company shall pay Executive a gross salary at the rate of $420,000 per year, less applicable withholdings, deductions and other taxes (&#147;<B>Base
Salary</B>&#148;). The Base Salary shall be paid in accordance with the Company&#146;s normal payroll practices. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> <B>Annual Bonus</B>. In further consideration of the Services to be rendered under
this Agreement, Executive shall be eligible to receive an annual discretionary bonus of up to fifty percent (50 %) of Base Salary, less applicable withholdings (&#147;<B>Annual Bonus</B>&#148;). The amount of any Annual Bonus shall be at the sole
discretion of the Board (or a committee thereof), which shall make its determination based on the based on achievement of goals and objectives established by the Company. Any Annual Bonus earned by Executive will be paid within <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">two-and-one-half</FONT></FONT></FONT> months of the end of the year in which it was earned. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>c.</B> <B>Employment Benefits Plans</B>. In further consideration of the Services to be rendered under this Agreement, Executive will be
entitled to participate in pension, profit sharing and other retirement plans, incentive compensation plans, group health, hospitalization and disability or other insurance plans, and other employee welfare benefit plans generally made available to
other similarly-situated employees of the Company, in accordance with the benefit plans established by the Company, and as may be amended from time to time in the Company&#146;s sole discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>d.</B> <B>Vacation</B>. Executive shall be eligible to receive paid vacation consistent with the policies and procedures adopted by the
Company, if any, in its sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>e.</B> <B>Expenses</B>. The Company will pay or reimburse Executive for all normal and
reasonable travel and entertainment expenses incurred by Executive in connection with Executive&#146;s responsibilities to the Company upon submission of proper vouchers and documentation in accordance with the Company&#146;s expense reimbursement
policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>f.</B> <B>Car Allowance</B>. The Company will provide Executive with a car allowance of $500 per month, less applicable
withholdings. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. <FONT STYLE="white-space:nowrap">At-Will</FONT> Employment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The employment of Executive shall be <FONT STYLE="white-space:nowrap">&#147;at-will&#148;</FONT> at all times. The Company or Executive may
terminate Executive&#146;s employment with the Company at any time, without any advance notice, for any reason or no reason at all, notwithstanding anything to the contrary contained in or arising from any statements, policies or practices of the
Company relating to the employment, discipline or termination of its employees. Following the termination of Executive&#146;s employment, the Company shall pay to Executive all compensation to which Executive is entitled up through the date of
termination and any employee benefits to which Executive is entitled (collectively, &#147;<B>Accrued Obligations</B>&#148;). Thereafter, all obligations of the Company under this Agreement shall cease other than those set forth in Section&nbsp;4.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Company Termination Obligations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B> <B>Termination by Company for Cause</B>. Where the Company terminates Executive&#146;s employment for Cause, all obligations of the
Company under this Agreement shall cease, other than any Accrued Obligations. For purposes of this Agreement, &#147;<B>Cause</B>&#148; shall mean: (i)&nbsp;Executive engages in misconduct, including but not limited to misappropriation of trade
secrets, fraud, or embezzlement; (ii)&nbsp;Executive commits a crime involving dishonesty, breach of trust, or physical harm to any person; (iii)&nbsp;Executive breaches this Agreement; (iv)&nbsp;Executive refuses to implement or follow a lawful
policy or directive of the Company; (v)&nbsp;Executive </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
engages in misfeasance or malfeasance demonstrated by Executive&#146;s failure to perform Executive&#146;s job duties diligently and/or professionally; or (vi)&nbsp;Executive violates a Company
policy or procedure which causes harm to the Company, including violation of the Company&#146;s policy concerning sexual harassment, discrimination or retaliation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> <B>Termination by Company without Cause</B>. Where the Company terminates Executive&#146;s employment without Cause, and
Executive&#146;s employment is not terminated due to death or Disability (as defined below), Executive will be eligible to receive, subject to applicable withholdings (i)&nbsp;continued payment of Base Salary for twelve (12)&nbsp;months following
the date that Executive&#146;s employment terminates according to the Company&#146;s normal payroll practices, and (ii)&nbsp;a pro rata portion of the Annual Bonus for the fiscal year in which Executive&#146;s employment terminates which shall be
payable when annual bonuses for such year are paid to other executives of the Company; provided that Executive&#146;s eligibility to receive the amounts in clauses (i)&nbsp;and (ii) of this Section&nbsp;4(b) is conditioned on Executive having first
signed a severance and general release agreement in the form provided by the Company and the release becoming irrevocable by its terms within fifty-five (55)&nbsp;calendar days following the date of Executive&#146;s termination of employment (or, if
applicable, the date of Executive&#146;s Separation from Service, as such term is defined in Section&nbsp;4(f)) and any payments that otherwise would have been paid to Executive during such period shall be paid to Executive with the first
installment paid to Executive following the end of such period. All other obligations of the Company under this Agreement shall cease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>c.</B> <B>Termination Due to Disability</B>. Executive&#146;s employment shall terminate automatically if Executive becomes Disabled.
Executive shall be deemed Disabled if Executive is unable for medical reasons to perform Executive&#146;s essential job duties for either ninety (90)&nbsp;consecutive calendar days or one hundred twenty (120)&nbsp;business days in a twelve
(12)&nbsp;month period and, within thirty (30)&nbsp;days after a notice of termination is given to Executive, Executive has not returned to work. If Executive&#146;s employment is terminated by the Company due to Executive&#146;s Disability, all
obligations of the Company under this Agreement shall cease, other than any Accrued Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>d.</B> <B>Termination Due to
Death</B>. Executive&#146;s employment shall terminate automatically upon Executive&#146;s death. If Executive&#146;s employment is terminated due to Executive&#146;s death, all obligations of the Company under this Agreement shall cease, other than
any Accrued Obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>e.</B> <B>Executive&#146;s Resignation</B>. Executive may resign Executive&#146;s employment at any time
during the Term of this Agreement pursuant to Section&nbsp;3, and thereafter, all obligations of the Company under this Agreement shall cease, other than any Accrued Obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>f.</B> <B>Section 409A; Delayed Payments</B>. To the extent applicable, the provisions in this Section&nbsp;4 are intended to comply with
Section&nbsp;409A of the Internal Revenue Code of 1986, as amended, and guidance promulgated thereunder (&#147;<B>409A</B>&#148;) and this Agreement shall be administered and construed in a manner consistent with this intent. In the event that any
compensation that becomes payable to Executive pursuant to this Section&nbsp;4 qualifies as a deferral of compensation within the meaning of and subject to 409A, then, notwithstanding anything to the contrary in this Agreement (i)&nbsp;such
compensation shall be paid to Executive only in the event of Executive&#146;s &#147;separation from service&#148; with the Company within the meaning of 409A </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(&#147;<B>Separation from Service</B>&#148;) and (ii)&nbsp;payment of that compensation shall be delayed if Executive is a &#147;<B>specified employee,</B>&#148; as defined in 409A(a)(2)(B)(i),
and such delayed payment is required by 409A. Such delay shall last six (6)&nbsp;months from the date of Executive&#146;s Separation from Service. On the Company&#146;s first payroll date that occurs after the end of such <FONT
STYLE="white-space:nowrap">six-month</FONT> period, the Company shall make a <FONT STYLE="white-space:nowrap">catch-up</FONT> payment to Executive equal to the total amount of such payments that would have been made during the <FONT
STYLE="white-space:nowrap">six-month</FONT> period but for this Section&nbsp;4(g). To the extent applicable, each and every payment to be made pursuant to Section&nbsp;4(b) shall be treated as a separate payment and not as one of a series of
payments treated as a single payment for purposes of Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2)(iii).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>g.</B> <B>Retainment of Rights</B>. This Agreement is separate and independent from the other agreements governing Executive&#146;s equity
in the Company and its organizational documents and for the avoidance of doubt, any termination of Executive&#146;s employment as Executive Chairman shall have no effect on his rights therein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Executive Termination Obligations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B> <B>Return of Property</B>. Executive agrees that all property (including without limitation all equipment, tangible proprietary
information, documents, records, notes, contracts and computer-generated materials) furnished to or created or prepared by Executive incident to Executive&#146;s employment belongs to the Company and shall be promptly returned to the Company upon
termination of Executive&#146;s employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> <B>Resignation and Cooperation</B>. Upon termination of Executive&#146;s
employment, Executive shall be deemed to have resigned from all offices and directorships then held with the Company. Following any termination of employment, Executive shall cooperate with the Company in the winding up of pending work on behalf of
the Company and the orderly transfer of work to other employees. Executive shall also cooperate with the Company in the defense of any action brought by any third party against the Company that relates to Executive&#146;s employment by the Company.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>c.</B> <B>Continuing Obligations</B>. Executive understands and agrees that Executive&#146;s obligations under Sections 6 and 7 herein
(including <U>Exhibits A</U> and <U>B</U>) and Section&nbsp;8 hereof shall survive the termination of Executive&#146;s employment for any reason and the termination of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Inventions and Proprietary Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Executive agrees to continue to be bound by the terms of the Proprietary Information and Inventions Agreement, which is attached as <U>Exhibit
A</U> (&#147;<B>Proprietary Information Agreement</B>&#148;). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Arbitration </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive agrees to continue to be bound by the terms of the Mutual Arbitration Agreement, which is attached as Exhibit B (&#147;<B>Mutual Arbitration
Agreement</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. <FONT STYLE="white-space:nowrap">Non-Competition</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive acknowledges and agrees with the Company that, during the course of Executive&#146;s employment with the Company, Executive has had and will continue
to have the opportunity to develop relationships with existing employees, customers, suppliers and other business contacts of the Company, which relationships constitute goodwill of the Company, and the Company would be irreparably damaged if
Executive were to take actions that would damage or misappropriate such goodwill. Accordingly, Executive agrees as follows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B>
<B><U>Noncompetition and Nonsolicitation</U></B>. In connection with Executive&#146;s employment, the Company agrees to provide Executive with access to confidential business and technical information of the Company and to provide Executive access
to its customers. To protect the legitimate business interests of the Company, including its trade secrets, confidential information, and goodwill, other than as excepted herein or with the written consent of the Board, Executive covenants and
agrees that, from the Effective Date and for the three (3)&nbsp;month period following the termination date of Executive&#146;s employment for any reason (the <B>&#147;Restricted Period&#148;</B>)<B>, </B>Executive will not, directly or indirectly,
either for himself or for any other Person: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) enter into, engage in, assist, give or lend funds to or otherwise finance, be employed by
or consult with, or have a financial or other interest in, a Competing Business in the United States, whether for or by himself or as an independent contractor, agent, stockholder, partner or joint venturer of or for any other Person (provided that
the foregoing shall not prohibit Executive from working for a Person that engages in a Competing Business as long as the business unit within which Executive is employed or otherwise performing services and Executive&#146;s actual services for such
Person are in no way engaged, directly or indirectly, in any Competing Business and provided further that nothing in this Section shall be construed to affect in any way Executive&#146;s confidentiality obligations as set forth in the Proprietary
Information Agreement. A &#147;<B>Competing Business</B>&#148; shall have the meaning set forth in Section&nbsp;1(b) hereof. The foregoing shall not be deemed to prohibit the Executive from acquiring solely as an investment up to one percent (1%) of
the outstanding equity interests of any publicly-held company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>(</B>ii) do anything to divert or attempt to divert from the Company
any business of any kind, including, without limitation, solicit or interfere with any of the Company&#146;s clients or other business partners with whom the Executive performed direct, substantive services during his employment or as to whom the
Executive had access to confidential information where his use or disclosure of confidential information could disadvantage the Company;<B> or</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) solicit, induce, recruit, encourage or hire any person engaged or employed by the Company who had access to Confidential Information to
terminate his or her employment or engagement with the Company.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> Executive acknowledges that the covenants provided for in this
Section&nbsp;8 are reasonable and necessary to protect the legitimate business interests of the Company, including its trade secrets, confidential information, and goodwill. Nevertheless, to the extent that the covenants provided for in this
Section&nbsp;8&nbsp;may later be deemed by a court or arbitrator to impose a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
greater restraint than is necessary to protect the goodwill or other business interests of the Company, such covenants shall be reformed, blue penciled or modified to the extent necessary to
cause the limitations contained in the covenants as to time, geographic area, and scope of activity to be restrained to impose a restraint that is not greater than necessary to protect the goodwill or other business interests of the Company and
enforce the covenant as reformed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>c.</B> <B><U>Executive Acknowledgment</U></B>. Executive understands that the foregoing restrictions
may limit his ability to earn a livelihood in a business similar to the business of the Company, but he nevertheless believes that he has received and will receive sufficient consideration and other benefits as an employee of the Company and as
otherwise provided hereunder or as described in the recitals hereto to clearly justify such restrictions which, in any event (given his education, skills and ability), Executive does not believe such restrictions would prevent him from otherwise
earning a living. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>d.</B> <B><U>Injunctive Relief</U></B>. Executive recognizes and agrees that a violation of any of the provisions
contained in Section&nbsp;8&nbsp;may cause irreparable damage to the Company, the exact amount of which may be impossible to ascertain, and that, for such reason, among others, the Company shall be entitled to seek an injunction without the
necessity of posting bond therefor in order to restrain any further violation of such provisions. Such right to seek an injunction shall be in addition to, and not in limitation of, any other rights and remedies the Company may have against
Executive, including, but not limited to, the recovery of damages. The terms and conditions of this Section&nbsp;8 shall survive termination of this Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Amendments; Waivers; Remedies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement may not
be amended or waived except by a writing signed by Executive and by the Company&#146;s Board. Failure to exercise any right under this Agreement shall not constitute a waiver of such right. Any waiver of any breach of this Agreement shall not
operate as a waiver of any subsequent breaches. All rights or remedies specified for a party herein shall be cumulative and in addition to all other rights and remedies of the party hereunder or under applicable law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Assignment; Binding Effect </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>a.</B>
<B>Assignment</B>. The performance of Executive is personal hereunder, and Executive agrees that Executive shall have no right to assign and shall not assign or purport to assign any rights or obligations under this Agreement. This Agreement may be
assigned or transferred by the Company; and nothing in this Agreement shall prevent the consolidation, merger or sale of the Company or a sale of any or all or substantially all of its assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>b.</B> <B>Binding Effect</B>. Subject to the foregoing restriction on assignment by Executive, this Agreement shall inure to the benefit of
and be binding upon each of the parties; the affiliates, officers, directors, agents, successors and assigns of the Company; and the heirs, devisees, spouses, legal representatives and successors of Executive. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Notices </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All notices or other communications required or permitted hereunder shall be made in writing and shall be deemed to have been duly given if delivered:
(a)&nbsp;by hand; (b)&nbsp;by a nationally recognized overnight courier service; or (c)&nbsp;by United States first class registered or certified mail, return receipt requested, to the principal address of the other party. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Severability </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any provision of this Agreement
shall be held by a court or arbitrator to be invalid, unenforceable, or void, such provision shall be enforced to the fullest extent permitted by law, and the remainder of this Agreement shall remain in full force and effect. In the event that the
time period or scope of any provision is declared by a court or arbitrator of competent jurisdiction to exceed the maximum time period or scope that such court or arbitrator deems enforceable, then such court or arbitrator shall reduce the time
period or scope to the maximum time period or scope permitted by law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Taxes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All amounts paid under this Agreement shall be paid less all applicable state and federal tax withholdings and any other withholdings required by any
applicable jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Governing Law </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This
Agreement shall be governed by and construed in accordance with the laws of the State of Texas. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Interpretation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement shall be construed as a whole, according to its fair meaning, and not in favor of or against any party. Sections and section headings contained
in this Agreement are for reference purposes only, and shall not affect in any manner the meaning or interpretation of this Agreement. Whenever the context requires, references to the singular shall include the plural and the plural the singular.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Obligations Survive Termination of Employment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive agrees that any and all of Executive&#146;s obligations under this Agreement, including but not limited to Exhibits A and B, shall survive the
termination of employment and the termination of this Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Counterparts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement may be executed in any number of counterparts, each of which shall be deemed an original of this Agreement, but all of which together shall
constitute one and the same instrument. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>18. Authority </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each party represents and warrants that such party has the right, power and authority to enter into and execute this Agreement and to perform and discharge all
of the obligations hereunder; and that this Agreement constitutes the valid and legally binding agreement and obligation of such party and is enforceable in accordance with its terms. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>19. Entire Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Agreement is intended to be
the final, complete, and exclusive statement of the terms of Executive&#146;s employment by the Company and replaces and supersedes the Original Agreement which shall terminate and be of no further force or effect as of the Effective Date. This
Agreement may not be contradicted by evidence of any prior or contemporaneous statements or agreements, except for agreements specifically referenced herein (including the Award Agreement, Proprietary Information Agreement, and Mutual Arbitration
Agreement). To the extent that the practices, policies or procedures of the Company, now or in the future, apply to Executive and are inconsistent with the terms of this Agreement, the provisions of this Agreement shall control. Any subsequent
change in Executive&#146;s duties, position, or compensation will not affect the validity or scope of this Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>20. Executive Acknowledgement
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>EXECUTIVE ACKNOWLEDGES EXECUTIVE HAS HAD THE OPPORTUNITY TO CONSULT LEGAL COUNSEL CONCERNING THIS AGREEMENT, THAT EXECUTIVE HAS READ AND
UNDERSTANDS THE AGREEMENT, THAT EXECUTIVE IS FULLY AWARE OF ITS LEGAL EFFECT, AND THAT EXECUTIVE HAS ENTERED INTO IT FREELY BASED ON EXECUTIVE&#146;S OWN JUDGMENT AND NOT ON ANY REPRESENTATIONS OR PROMISES OTHER THAN THOSE CONTAINED IN THIS
AGREEMENT. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL></B><SMALL></SMALL>, the parties have duly executed this Agreement as of
the date first written above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">COYA THERAPEUTICS, INC. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ David S. Snyder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">/s/ Howard Berman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By: David S. Snyder</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Howard Berman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its: CFO/COO</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: October&nbsp;30, 2024</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Dated: October&nbsp;30, 2024</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPRIETARY INFORMATION AGREEMENT </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MUTUAL ARBITRATION AGREEMENT </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>coya-20241028.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241008.3 -->
<!-- Creation date: 11/1/2024 12:18:07 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:coya="http://www.coyatherapeutics.com/20241028"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.coyatherapeutics.com/20241028"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="coya-20241028_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="coya-20241028_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>coya-20241028_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241008.3 -->
<!-- Creation date: 11/1/2024 12:18:07 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>coya-20241028_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20241008.3 -->
<!-- Creation date: 11/1/2024 12:18:07 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="coya-20241028.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm46399922778512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001835022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 28,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Coya Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">85-4017781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5850 San Felipe St.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">587-8170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">COYA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M@@O\%'G>SQA*LS;XN*E_EC%$9;J6 C.W#I$PZI]'?A]-]V8M\''/_J:X,4Q
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M>FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ
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M4')O<',O8V]R92YX;6Q02P$"% ,4    "  ]A5]9F5R<(Q &  "<)P  $P
M            @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M #V%7UGFXGV#?@0  ,H1   8              " @0X(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    "  ]A5]9GZ ;\+$"  #B#   #0
M            @ '"#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( #V%7UF7
MBKL<P    !,"   +              "  9X/  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( #V%7UD<.&7J/P$  #P"   /              "  8<0  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    "  ]A5]9)!Z;HJT   #X 0  &@
M        @ 'S$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    "  ]A5]999!YDAD!  #/ P  $P              @ '8$@  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   B%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d840498d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>coya-20241028.xsd</File>
    <File>coya-20241028_lab.xml</File>
    <File>coya-20241028_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="d840498d8k.htm">d840498d8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d840498d8k.htm": {
   "nsprefix": "coya",
   "nsuri": "http://www.coyatherapeutics.com/20241028",
   "dts": {
    "schema": {
     "local": [
      "coya-20241028.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "coya-20241028_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "coya-20241028_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "d840498d8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-10-28_to_2024-10-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d840498d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-10-28_to_2024-10-28",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d840498d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.coyatherapeutics.com//20241028/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-24-248755-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-248755-xbrl.zip
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MT521[IZ[1_Z=PLA6WK[?+&*X)T)2SDYZ?O^H!X2%/*)L=M);22^0(:4]D$G
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MT[E)Z!T  9A2,P$)?1Q3-=[BLJ@?TOOJ@;#I42,*3RP"7O/GS-;B$!M9FUJ
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MIXQ0[29]0[\$ Y"& CQM PQ87P>X$V]8KD ND590GPZPW)!>3RS2M;I"DXG
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MS:(9J%%6V_KQ*:M;#H[>3 ]NS*.V<P_IY3(M$ZNHNH]6^]"4>=/IBFU$LLK
MQ%\RE<YV0&]E%9='6\J/BJ( H4*K V,:.-04MA5:D]Y\D,$B CUWJ0V:>2IC
M3=O3W]ERS3T2\/V">[";VHZ BR1U[<10'Q$Z0A!P^58WP6<^ "2^^9%BG>["
M9G93##3*>*8=#OX_8@D(OK TJ)+0_(DL$>E.&Q"@-4JS06LEPC?67H='QXKX
M(RM!S[>G.YZ'!_6Q3"UEE%3&7IW5P=]96LX7]<4$,E;HK>15R:+;B7*PX'!2
M8%I*JW@N00A##_BZ>TCW;'57 <1*9E_&,OD\G@$'_H5,PZ AJ>FQMME\/QMJ
M%*1YLX,**2ICE=E(.R3,C.EEA6LF;1]'O%)L7!J51/\* ABXS4+)N%B@59FO
MH@*4R3\JO07(79*U3"9]JKTY>9F1(-+#P(/=CF=YP'Y4/$/_]Y2!R(^*.7S*
MR NT)%?@E03QHQ&"![ 2:==*)#-FTQN\02SZ<V[F$.QL!B(QXFR)IW4W;S)Z
MVJP[^3Y0M[)F?Y/L=:V;LFWRR)(?L;TK_2;C=%ZP$:JAN4ICC"_:>*;6,KH=
MXXBO S4B64*G@]13][G?!Y!41=^?D J,-VWBL#:B0%114R2D:#DML]QSE:"$
MB^-N1^MY[%"28%XS!F=@AO.W9*YAM)<H4>D9D1;+;(-UG#!KWN#":OBM:O$M
M] :*O)PN@>MJ9H1F.Y#355H&0%9\>&$:E+@D>5/<J8;C>O6HOVB0:$<T(,6M
M)OECI+AI&O[P<*W66[6:?K'['JC$Z":.K'P89BV2LQ,M26=M7/#67;+B+(M=
MY BL+)L=@R:,HZ!,R'WN <S!\\IU.T:_;8DF.FML:%@X!2I:,$6/?DW+0H=[
M.<24I&A5]I@?)=>:!['KW'S@=?;P62^^!\^C@CLW# 2S4C(=\ZC24W#@+,KQ
M.?8/HP4/7,.$JJQ$0/=\+53;[9B-4,#;F:O:=(_$0;3"'#L<P[4$T.5>Y)7,
MWQ.O*"O%C54XS]X VDT>""\4CE]ZFA'\RAJUGWI@M#(TSAP5.&1G17781F_"
M*:TN-#6*Y"V#;PK)]8,@PW#(1>6LK=MQ.N#?HPVY3MV:\=[J;V;8! IM2^TV
MP40S0#WX(E<%HAI@:<.",+EFF.2XVI#DV"!QX=+TBYH,^--S)4VBXN[^KM!K
M?_0$?_<R]?G#E:F&\"8.@W#H^($(3L\?["X55%77C7@BRURQZOP>F8[O&S "
M+[]1XMEQ-C&K2H3<QJUZ+KLB_U634Z( R3"BO$IS(Z5\([Q*Q36[8\YJ7%9*
M)DXLO&+='/2FR"THWB!!T?_L!MBF(+DQC!>#3:M3O^!!2A%995'E-\"TF&XG
M5V@A@7B=9;(,*:B&2<A__!'3.MUP>[4&=KCEZ'K+V%"]2N,KG!Q$[")-P/@%
M28(D!E*'YBKS@L9>+:[S*  [9B&SI0D?<KCPI1O7=M+&:!2T/CP XM-7C8<S
M-2MSME0B.'OMQ,MTCBFL-Y;K60G6%%L2%$*D= %\V1=:,$%S?!_X,\ &J:.+
M8)O9CZ%: @H4F2QJ9I?-ZY)17&9D$9O,OL8SOZ=3DT00@@$VAYW$USH!AWPQ
MBJPN=&MP4L!5$W8ZDHL'I7?E[MQ:U5H]""3!SIQ,S>=AT(O'=#RQ-=--CP^(
M&:@L(=^_^E3RB<L\KS0QP!RK4I$3"<2(_/(DZV_GL]_ B8Q6_"VXD3>6=F7=
M]'R4$TG;T<&J+@E]0B4Y<^FT<IEM2W1TSTBOGBK ^YU6EU_3+=-#:QY]W$28
MFSS\!LU0>8\2Y'N@WQK+QXUF(<LMUBJ&2;>?[>NWM&=Y9M1K3B<BC79#DD,%
M!0>X[$-P]/S/C(KU3"Z=R9]!*L#H'R9H92Y:>RY\6MHZ+>.0\QZF6&E!3BQ/
MKZ<=8UX,H#>\ZSO+ZSOK=MJWY@8N*$)PS8>P4#:&0U$;$TS#9#AV@&?*KDG[
M13>%TU[6,NJ:4"?L8'RJN<TY=L.I0S&S#(L3!KA6X#6<_X#*F!^9<!(Q1UPJ
M  )PR?Z+LAQ$+B<12V @5XI=OSB^]N:BI4>V@[0R6OM+B9_:_=72MG$$"OCJ
MMVT*2)1EZBIEA(=WR'""0\E-=(9"8[LS7.7VCS\:&C 1B!"4[@JI?2NM =R:
M->F@P7::L2?3$E_/':MY3F.UDCH60$:S#@10RC)A!F79115#: 9D9CL[UGC4
ME*P1GI!H'0&4;D=]G=C'2>8JBU+@:'XXVWO<.B#XJ$$/!_8?LY.OA:Q<N.H
MD#/3GNBC2L>Y?%]NA=Z/W E:Y<XIL_>*J]?<ZRW<D7=2^7]D"6N$T0**?$2N
M5XJ0'E9"P\<J]#+2[:GI-#[SD#]$A"GG1"S(A. YTNK8$93?J-B WJ(381T5
M!P?1:;N@,RB48K\\K01-;C5/C^ P.)0 UX"310\W")L$WWRV;UZU"8_T./J>
MM43J=FHB2:,24D+/D#S\)\/Q?C##T2BZQD%[Q C)G(,#N,QAH8F'P3V/Q;$L
M!X6GS'21Q#K-/NZ)X8V.)1S9D?\UMJ;5@<;[%0+U.(SP%?3Q>7;/O0:CFB34
M[9RBBO2UY$.QCF:2+PY]QX/;=%(TUE=[TMPSZG9N/J3OT8'VP]_"@78G>'[+
M*&4-)T<*=;#6\"X&KS/Z^6;%U@LL:.7K6[F-/Y\A_=5"?69AJI4M\?SI+_V7
MXE3%$C-<+K6>I>/!.E3QB4+@==V/--F<X&.*>'T-CA1_3'VG- +@+1A:B-E@
MQ=00]UE8A8'R$'$2R_A&H%Z#'0=@#TF</?OEQ4]<\\:9"7QN\S+BF"T6%Y?Q
MG,L*JU*&*O,+)ZD7EK<>(N7R 5_$V#_*;WPP(,])R9JJA+-)$I/UXF4(4.U"
M045N0U;[<1<%*Z[DZ/ #+/BU47N,2>4IF53](9."#<HFD/\#AA>6_7&-)>K3
M*LNXY,J;R>H.BGQXJ+52FEOH&M<((CK=Y [1LD8)=V5WH3)<V_$-RG>:Q+8Z
ME:'69EKP>>8U T,7NVI?92..V+Y[0KL*0388+76<J:QTQ\% !^ENU#$S0DU=
M=4555L[6?*4"+MXT<;*>XWJ5GIV$J]Z6.]O[.]O'.P#JGCY%+,'5,YF%19@M
M454AX)M[8FR?U(<12[)J/XGMGVK>$$K]N8.=9S.^]L1%:Y(0FU7&_5&Y5](@
M*#.CP]:MJ5MCU+#V75JRB4RSTMP6\Z242WG[D($L@L5NN;(C:HAZ"*N0^#0]
M=#M%6F BC$TA94O0LUSK]BKE?3FU9U^Z4W*NLY>GZ=R8[]S$RLD73GDZ5RJ[
M=O<Y5;P^EP,U_"8.FA=4,18R']+TJ>R . 7:%]A3)"%DPH<H]QH3="R8O$$
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M)NC>L=7)ETY7A6&ERSP01:^IPZ7"))EH.WD*-K^-?7%X7GLS-VT-M^U P4G
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M/BQUSF:@0]C:,6";R3@-56MM%-H;!S*&W-2EK7ZU #;@T/$QYVY+NGLUXF0
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MBD5666##O=2N0VD+M+G;+3MM/[ES=[T?^J2C3BWED8O/D@X<[9XRR2>PK,B
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MR7 /^0_4.T A[13GV)OB-'>?/]?,+1*)E<W F;<.M[K.2I.V-9_*88/=+$=
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MG4B>X4:SB8 =P^@E5=)&? 8IW2S->/@$]'_@5_3=\-Q!A4WQ[2G!78I0WBA
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M)F6!%2EBMA<W&,-\!3(Z#AHPV$8E<70*KBOC)B^6NH:K_!0\V@V4Z%&,NO
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M82TR,#(T,3 R.%]L86(N>&UL4$L! A0#%     @ /85?69T[+WG?!   $"X
M !4              ( !3@H  &-O>6$M,C R-#$P,CA?<')E+GAM;%!+ 0(4
M Q0    ( #V%7UF3 H6.J1(  $AW   .              "  6 /  !D.#0P
M-#DX9#AK+FAT;5!+ 0(4 Q0    ( #V%7UG@[WA?C28  %ZZ   1
M      "  34B  !D.#0P-#DX9&5X,3 Q+FAT;5!+ 0(4 Q0    ( #V%7UG\
M%=$Y6"@  %>P   1              "  ?%(  !D.#0P-#DX9&5X,3 R+FAT
7;5!+!08     !@ & '\!  !X<0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d840498d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="coya-20241028.xsd" xlink:type="simple"/>
    <context id="duration_2024-10-28_to_2024-10-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001835022</identifier>
        </entity>
        <period>
            <startDate>2024-10-28</startDate>
            <endDate>2024-10-28</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-278">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-10-28_to_2024-10-28"
      id="Hidden_dei_EntityCentralIndexKey">0001835022</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-289">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-290">2024-10-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-291">Coya Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-292">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-293">001-41583</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-294">85-4017781</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-295">5850 San Felipe St.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-296">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-297">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-298">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-299">77057</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-300">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-301">587-8170</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-302">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-303">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-304">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-305">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-306">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-307">COYA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-308">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-309">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2024-10-28_to_2024-10-28" id="ixv-310">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
